Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders

Bipolar Disorders

Volumn 7, Issue 5, 2005, Pages 404-417

  Kleindienst, Nikolaus ^a   Engel, R R ^a   Greil, W ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Private Psychiatric Hospital   (Switzerland)

Author keywords

Bipolar disorder; Lithium; Meta analysis; Treatment outcome

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; OLANZAPINE; VALPROIC ACID;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; CALCULATION; CLINICAL FEATURE; CLINICAL TRIAL; DRUG RESPONSE; EVIDENCE BASED MEDICINE; HOSPITALIZATION; HUMAN; META ANALYSIS; ONSET AGE; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; PROTECTION; RECURRENT DISEASE; RELIABILITY; REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

AGE FACTORS; ANTIMANIC AGENTS; BIPOLAR DISORDER; HOSPITALIZATION; HUMANS; LITHIUM CARBONATE; PSYCHOTIC DISORDERS; TIME FACTORS;

EID: 26444608720     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2005.00244.x     Document Type: Review

References (74)

1. Goodwin FK. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder. J Clin Psychiatry 2003; 64 (Suppl. 5): 18-24.
2. Bauer MS, Mitchner L. What is a 'mood stabilizer'? An evidence-based response. Am J Psychiatry 2004; 161: 3-18.
3. Schou M. Lithium treatment at 52. J Affect Disord 2001; 67: 21-32.
4. Kleindienst N, Greil W. Lithium in the long-term treatment of bipolar disorders. Eur Arch Psychiatry Neurol Sci 2003; 253: 120-125.
5. Moncrieff J. Lithium: evidence reconsidered. Br J Psychiatry 1997; 171: 113-119.
6. Coryell W, Winokur G, Solomon D, Shea T, Leon A, Keller MB. Lithium and recurrence in a long-term follow-up of bipolar affective disorder. Psychol Med 1997; 27: 281-289.
7. Kleindienst N, Greil W, Rüger B, Möller HJ. The prophylactic efficacy of lithium-transient or persistent? Eur Arch Psychiatry Clin Neurosci 1999; 249: 144-149.
8. Grof P. Selecting effective long-term treatment for bipolar patients: monotherapy and combinations. J Clin Psychiatry 2003; 64 (Suppl. 5): 53-61.
9. Baastrup PC, Schou M. Lithium as a prophylactic agent. Its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 1967; 16: 162-172.
10. Maj M, Pirozzi R, Magliano L, Bartoli L. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. Am J Psychiatry 1998; 155: 30-35.
11. Yazici O, Kora K, Ücok A, Tunali D, Turan N. Predictors of lithium prophylaxis in bipolar patients. J Affect Disord 1999; 55: 133-142.
12. Ayuso-Gutierrez JL, Ramos-Brieva JA. The course of manic-depressive illness. A comparative study of bipolar I and bipolar II patients. J Affect Disord 1982; 4: 9-14.
13. Hartong EG, Moleman P, Hoogduin CA, Broekman TG, Nolen WA, LitCar Group. Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry 2003; 64: 144-151.
14. Mander AJ. Clinical prediction of outcome and lithium response in bipolar affective disorder. J Affect Disord 1986; 11: 35-41.
15. Grof P, Aida M, Grof E, Fox D, Cameron P. The challenge of predicting response to stabilising lithium treatment. The importance of patient selection. Br J Psychiatry 1993; 21 (Suppl.): 16-19.
16. Preisig M, Angst J. Maladies dépressives. Facteurs du risque du récidive. Encéphale 1991; 17: 365-372.
17. Baethge C, Tondo L, Bratti IM et al. Prophylaxis latency and outcome in bipolar disorders. Can J Psychiatry 2003; 48: 449-457.
18. Kleindienst N, Engel RR, Greil W. Psychosocial and demographic factors associated with response to prophylactic lithium. A systematic review for bipolar disorders. Psychol Med (in press).
19. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. In: Chalmers I, Altman DG eds. Systematic Reviews. London: BMJ Publishing Group, 1995: 17-36.
20. Rosenthal R. Meta-analytic Procedures for Social Research. Newbury Park, CA: Sage, 1991.
21. Sinclair JC, Bracken B. Clinically useful measures of effect in binary analyses of randomized trials. J Clin Epidemiol 1994; 47: 881-889.
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
23. Melia PI. Prophylactic lithium: a double-blind trial in recurrent affective disorders. Br J Psychiatry 1970; 116: 621-624.
24. Cundall RL, Brooks PW, Murray LG. A controlled evaluation of lithium prophylaxis in affective disorders. Psychol Med 1972; 2: 308-311.
25. Persson G. Lithium prophylaxis in affective disorders. An open trial with matched controls. Acta Psychiatr Scand 1972; 48: 462-479.
26. Prien RF, Caffey EM, Klett J. Prophylactic efficacy of lithium carbonate in manic depressive illness. Arch Gen Psychiatry 1973; 28: 337-341.
27. Prien RF, Caffey EM Jr, Klett CJ. Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry 1974; 31: 189-192.
28. Dunner DL, Fieve RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974; 30: 229-233.
29. Dunner DL, Fleiss JL, Fieve RR. Lithium carbonate prophylaxis failure. Br J Psychiatry 1976; 129: 40-44.
30. Ananth J, Engelsmann F, Kiriakos R, Kolivakis T. Prediction of lithium response. Acta Psychiatr Scand 1979; 60: 279-286.
31. Kocsis JH, Stokes PE. Lithium maintenance: factors affecting outcome. Am J Psychiatry 1979; 136: 563-566.
32. Rosenthal NE, Rosenthal LN, Stallone F, Fleiss J, Dunner DL, Fieve RR. Psychosis as a predictor of response to lithium maintenance treatment in bipolar affective disorder. J Affect Disord 1979; 1: 237-245.
33. Faravelli C, Marchetti G, Benvenuti P, Cabras PL. Il Litio Nella Prevenzione Delle Turbe Cicliche Dell'Affettivita. Riv Patol Nerv Ment 1980; 101: 261-271.
34. Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatment. Pharmacopsychiatry 1980; 13: 156-167.
35. Kukopulos A, Reginaldi D. Recurrences of manic-depressive episodes during lithium treatment. In: Johnson FN ed. Handbook of Lithium Therapy. Lancaster: University of Lancaster, 1980: 109-117.
36. Sarantidis D, Waters B. Predictors of lithium prophylaxis effectiveness. Prog Neuropsychopharmacol 1981; 5: 507-510.
37. Abou-Saleh MT. Platelet MAO, personality and response to lithium prophylaxis. J Affect Disord 1983; 5: 55-65.
38. Hanus H, Zapletalek M. The prophylactic lithium treatment in affective disorders and the possibilities of the outcome prediction. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove 1984; 27: 5-75.
39. Yang YY. Prophylactic efficacy of lithium and its effective plasma levels in Chinese bipolar patients. Acta Psychiatr Scand 1985; 71: 171-175.
40. Abou-Saleh MT, Coppen A. Who responds to prophylactic lithium? J Affect Disord 1986; 10: 115-125.
41. Bouman TK, Niemantsverdriet-van Kampen JG, Ormel J, Slooff CJ. The effectiveness of lithium prophylaxis in bipolar and unipolar depressions and schizo-affective disorders. J Affect Disord 1986; 11: 275-280.
42. Haag M, Heidorn A, Haag H, Greil W. Response to stabilising lithium therapy and sequence of affective polarity. Pharmacopsychiatry 1986; 19: 278-279.
43. Haag M, Heidorn A, Haag H, Greil W. Sequence of affective polarity and lithium response: preliminary report on Munich sample. Neuropsychopharmacol Biol Psychiatry 1987; 11: 205-208.
44. Maj M, Starace F, Nolfe G, Kemali D. Minimum plasma lithium levels required for effective prophylaxis in DSM III bipolar disorder: a prospective study. Pharmacopsychiatry 1986; 19: 420-423.
45. Grof E, Haag M, Grof P, Haag H. Lithium response and the sequence of episode polarities: preliminary report on a Hamilton sample. Prog Neuropsychopharmacol Biol Psychiatry 1987; 11: 199-203.
46. Lusznat RM, Murphy DP, Nunn CM. Carbamazepine vs lithium in the treatment and prophylaxis of mania. Br J Psychiatry 1988; 153: 198-204.
47. Gelenberg AJ, Kane JM, Keller MB et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989; 321: 1489-1493.
48. Faedda GL, Baldessarini RJ, Tohen M, Strakowski SM, Waternaux C. Episode sequence in bipolar disorder and response to lithium treatment. Am J Psychiatry 1991; 148: 1237-1239.
49. Maj M, Pirozzi R, Starace F. Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients. J Affect Disord 1989; 17: 237-241.
50. Maj M. Clinical prediction of response to lithium prophylaxis in bipolar patients: the importance of the previous pattern of course of the illness. Clin Neuropharmacol 1990; 13 (Suppl. 1): 66-70.
51. O'Connell RA, Mayo JA, Flatow L, Cuthbertson B, O'Brien B. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 1991; 159: 123-129.
52. Gasperini M, Scherillo P, Manfredonia MG, Franchini L, Smeraldi E. A study of relapses in subjects with mood disorder on lithium treatment. Eur Neuropsychopharmacol 1993; 3: 103-110.
53. Okuma T. Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology 1993; 27: 138-145.
54. Young LT, Cooke RG, Robb JC, Levitt AJ, Joffe RT. Anxious and non-anxious bipolar disorder. J Affect Disord 1993; 29: 49-52.
55. Maj M, Pirozzi R, Magliano L. Late non-response to lithium prophylaxis in bipolar patients: prevalence and predictors. J Affect Disord 1996; 39: 39-42.
56. Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997; 58: 470-478.
57. Kusalic M, Engelsmann F. Predictors of lithium treatment responsiveness in bipolar patients. A two-year prospective study. Neuropsychobiology 1998; 37: 146-149.
58. Tondo L, Baldessarini RJ, Hermen J, Floris G. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry 1998; 155: 638-645.
59. Kulhara P, Basu D, Mattoo SK, Sharan P, Chopra R. Lithium prophylaxis of recurrent bipolar affective disorder: long-term outcome and its psychosocial correlates. J Affect Disord 1999; 54: 87-96.
60. Baldessarini RJ, Tondo L, Floris G, Hennen J. Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients. J Affect Disord 2000; 61: 13-22.
61. Coryell W, Akiskal H, Leon AC, Turvey C, Solomon D, Endicott J. Family history and symptom levels during treatment for bipolar I affective disorder. Biol Psychiatry 2000; 47: 1034-1042.
62. Kato T, Inubushi T, Kato N. Prediction of lithium response by 31P-MRS in bipolar disorder. Int J Neuropsychopharmacol 2000; 3: 83-85.
63. Schürhoff F, Bellivier F, Jouvent R et al. Early and late onset bipolar disorders: two different forms of manic-depressive illness? J Affect Disord 2000; 58: 215-221.
64. Tondo L, Baldessarini RJ, Floris G. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders. Br J Psychiatry 2001; 178 (Suppl. 41): 184-190.
65. Franchini L, Zanardi R, Smeraldi E, Gasperini M. Early onset of lithium prophylaxis as a predictor of good long-term outcome. Eur Arch Psychiatry Neurol Sci 1999; 249: 227-230.
66. Angst J. The course of affective disorders. II. Typology of bipolar manic-depressive illness. Arch Psychiatr Nervenkr 1978; 226: 65-73.
67. Aronoff MS, Epstein RS. Factors associated with poor response to lithium carbonate: a clinical study. Am J Psychiatry 1970; 127: 472-480.
68. Small JG, Klapper MH, Milstein V et al. Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry 1991; 48: 915-921.
69. Grof P, Hux M, Grof E, Arato M. Prediction of response to stabilizing lithium treatment. Pharmacopsychiatry 1983; 16: 195-200.
70. Carroll BJ. Prediction of treatment outcome with lithium. Arch Gen Psychiatry 1979; 36: 870-878.
71. Grof P, Lane J, Hux M, Daigle L, Grof E, Werstiuk E. Predicting the response to long-term lithium treatment. Interim results of a prospective study. In: Dufour H, Pringuey D, Milech T eds. La Prédiction de la Réponse au Lithium. Marseille: Université de Marseille, 1983: 43-53.
72. Brochier T, Gay C. l'efficacité des thymorégulateurs. L'Encéphale 1991; 16: 391-398.
73. Calabrese JR, Fatemi SH, Kujawa M, Woyshville MJ. Predictors of response to mood stabilizers. J Clin Psychopharmacol 1996; 16 (Suppl. 1): 24-31.
74. Walden J, Normann C, Langosch J, Grunze H. Wirksamkeitsprädiktoren für Phasenprophylaktika (Stimmungsstabilisierer) bei bipolar affektiven Störungen. Fortschr Neurol Psychiatry 1999; 67: 75-80.